We remain steadfast in our commitment to help patients access the Rituxan they have been prescribed.

If your patients:

Need help understanding insurance coverage and related financial responsibilities, Rituxan Immunology Access Solutions is here to help

  • Contact your Genentech representative if you have questions about coverage or financial assistance options

Do not have insurance coverage or have financial concerns and meet certain eligibility criteria, the Genentech Patient Foundation may be able to provide free medicine*

Have insurance and need help paying for their medicine, Affordability Options may be available

  • With the Rituxan Immunology Co-pay Card Program, eligible, commercially insured patients pay $5 per drug co-pay (up to $15,000 in assistance per 12-month period) and $5 per infusion co-pay (up to $2,000 in assistance per 12-month period)†‡
  • We offer referrals to independent co-pay assistance foundations for eligible patients who have public or commercial insurance§

    The final amount owed by patients may be as little as $5, but may vary depending on the patient's health insurance plan. There are different criteria for drug and infusion assistance.

Want information and resources about Rituxan, Rituxan Patient Education and Treatment Resources provides answers to their questions

*To be eligible for free Genentech medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine must have pursued all other forms of financial assistance and meet certain income requirements. Uninsured patients and insured patients without coverage for their medicine must meet different income requirements.

This Rituxan Immunology Co-pay Card Program is valid ONLY for patients with commercial insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medication. Patients using Medicare, Medicaid or any other federal or state government funded program to pay for their medication or associated administration fees are not eligible. Patients who start utilizing their Government Program insurance during their enrollment period will no longer be eligible for the program. The Administration Co-pay Program is not valid for administration fees for Massachusetts, Michigan, Minnesota, or Rhode Island residents. To receive co-pay assistance for both drug cost and administration fees, patients must apply for and be enrolled in each type of Program benefit, i.e., drug cost and administration fees. Under the Program, the patient will pay a co-pay for Rituxan (drug cost) and a co-pay for administration fees of Rituxan if enrolled for both types of Program benefit. After reaching the maximum per treatment or annual limit for drug costs and/or administration fees, as applicable, the patient will be responsible for all remaining Out-of-Pocket expenses. The amount of the Program benefit cannot exceed the patient’s Out-of-Pocket expenses for the cost of Rituxan and/or, as applicable, the administration fees associated with Rituxan. Once enrolled, this Program will not honor claims with a date of service that precede Program enrollment by more than 120 days. This Program is not health insurance or a benefit plan. Participating patients, physician offices, and hospitals are responsible for reporting the receipt of all Program benefits as may be required, to any insurer, health plan, or other third party who pays for or reimburses any part of the drug costs and/or administration fees using the Program. The patient, guardian, prescriber, hospital and any other person using or administering the Program agree not to seek reimbursement for all or any part of the benefit received by the patient through the offer of this Program. The patient or guardian must be 18 years or older to receive Program benefits. This Program is void if the card is reproduced and where prohibited by law. It is only valid for Rituxan and/or its administration, as applicable, and only valid in the U.S. and U.S. Territories. The Program is not valid where prohibited by law. Genentech, Inc. reserves the right to rescind, revoke, or amend the Program without notice at any time. Additional eligibility and Terms and Conditions apply. Please visit for the full list of Terms and Conditions.

§Genentech does not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from Rituxan Immunology Access Solutions. The foundations to which we refer patients are not exhaustive or indicative of Genentech’s endorsement or financial support. There may be other foundations to support the patient’s disease state.